• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Drug removal in continuous haemofiltration and haemodialysis.

作者信息

Davies J G, Kingswood J C, Sharpstone P, Street M K

机构信息

Department of Pharmacy, University of Brighton.

出版信息

Br J Hosp Med. 1995;54(10):524-8.

PMID:8574497
Abstract

Although both continuous haemofiltration and continuous haemodialysis are techniques routinely employed in the management of critically ill patients, deciding on a drug dosing regimen is often difficult. This article highlights the factors influencing drug removal by both processes, the difficulties associated with the interpretation of research in this area and offers a number of approaches which can be used when selecting a dosing regimen for a patient receiving one of these therapies.

摘要

相似文献

1
Drug removal in continuous haemofiltration and haemodialysis.
Br J Hosp Med. 1995;54(10):524-8.
2
Drug administration in critically ill patients with acute renal failure.急性肾衰竭重症患者的药物给药
New Horiz. 1995 Nov;3(4):748-59.
3
Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.美罗培南在接受持续静静脉血液滤过的急性肾衰竭重症患者中的药代动力学
Clin Pharmacol Ther. 1999 Jan;65(1):50-7. doi: 10.1016/S0009-9236(99)70121-9.
4
Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients.危重症患者持续静静脉血液滤过或血液透析滤过期间的药代动力学及药物剂量调整
Acta Anaesthesiol Scand. 2001 Sep;45(8):929-34. doi: 10.1034/j.1399-6576.2001.450802.x.
5
The impact of continuous renal replacement therapy on drug therapy.连续性肾脏替代治疗对药物治疗的影响。
Clin Pharmacol Ther. 2009 Nov;86(5):562-5. doi: 10.1038/clpt.2009.152. Epub 2009 Sep 2.
6
[Acute renal replacement therapy in the intensive care unit].[重症监护病房中的急性肾脏替代治疗]
Ned Tijdschr Geneeskd. 2001 Dec 1;145(48):2317-21.
7
Clinical pharmacokinetics during continuous haemofiltration.持续血液滤过期间的临床药代动力学
Clin Pharmacokinet. 1994 Jun;26(6):457-71. doi: 10.2165/00003088-199426060-00004.
8
Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.持续肾脏替代治疗患者的药物剂量。药代动力学及治疗方面的考量。
Clin Pharmacokinet. 1993 May;24(5):362-79. doi: 10.2165/00003088-199324050-00002.
9
Renal replacement therapy for acute renal failure.
Clin Intensive Care. 1990;1(6):268-73.
10
[Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].[连续性肾脏替代治疗(CRRT)期间的药代动力学原理及药物剂量调整]
G Ital Nefrol. 2006 May-Jun;23 Suppl 36:S127-38.

引用本文的文献

1
Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.间歇性血液透析和连续性肾脏替代治疗期间的药物剂量:儿科患者的特殊考量
Paediatr Drugs. 2004;6(1):45-65. doi: 10.2165/00148581-200406010-00004.
2
Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration.异帕米星在持续静静脉血液透析滤过过程中的药代动力学
Antimicrob Agents Chemother. 1999 Oct;43(10):2409-11. doi: 10.1128/AAC.43.10.2409.
3
Pharmacokinetics of cefepime during continuous venovenous hemodiafiltration.
头孢吡肟在持续静静脉血液透析滤过过程中的药代动力学
Antimicrob Agents Chemother. 1997 Nov;41(11):2424-7. doi: 10.1128/AAC.41.11.2424.